10-Q Filing

CVS HEALTH CORP CIK: 64803 Q1 2019

Filing Information

Form Type	10-Q
Accession Number	`0000064803-19-000021`
Period End Date	20190331
Filing Date	20190501
Fiscal Year	2019
Fiscal Period	Q1
XBRL Instance	cvs-20190331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 38 Cash Flow Statement 80 Stockholders Equity 49 Comprehensive Income 16

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.06B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.90B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.43B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.52B	USD	Point-in-time
Total accounts receivable, net	`AccountsReceivableNetCurrent`	$17.63B	USD	Point-in-time
Total accounts receivable, net	`AccountsReceivableNetCurrent`	$19.51B	USD	Point-in-time
Inventories	`InventoryNet`	$16.45B	USD	Point-in-time
Inventories	`InventoryNet`	$15.45B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.58B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.58B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$47.86B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$45.24B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$15.73B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$16.41B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.35B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.35B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.99B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Goodwill	`Goodwill`	$79.08B	USD	Point-in-time
Goodwill	`Goodwill`	$78.68B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$36.52B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$35.15B	USD	Point-in-time
Separate account assets	`SeparateAccountAssets`	$4.07B	USD	Point-in-time
Separate account assets	`SeparateAccountAssets`	$3.88B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.87B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.05B	USD	Point-in-time
Total assets	`Assets`	$219.77B	USD	Point-in-time
Total assets	`Assets`	$196.46B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$8.29B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$8.93B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$11.37B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$11.83B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$6.15B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$6.70B	USD	Point-in-time
Other Policyholder Funds	`OtherPolicyholderFunds`	$2.73B	USD	Point-in-time
Other Policyholder Funds	`OtherPolicyholderFunds`	$2.94B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$10.71B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$10.44B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.94B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.94B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.80B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$3.00B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$720.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.89B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$1.26B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$50.63B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$44.01B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.96B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$71.44B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$67.89B	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$7.68B	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$7.54B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.07B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.88B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$8.05B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$8.12B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.62B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.78B	USD	Point-in-time
Total liabilities	`Liabilities`	$137.91B	USD	Point-in-time
Total liabilities	`Liabilities`	$159.76B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,722 shares issued and 1,298 shares outstanding at March 31, 2019 and 1,720 shares issued and 1,295 shares outstanding at December 31, 2018	`CommonStocksIncludingAdditionalPaidInCapital`	$45.62B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,722 shares issued and 1,298 shares outstanding at March 31, 2019 and 1,720 shares issued and 1,295 shares outstanding at December 31, 2018	`CommonStocksIncludingAdditionalPaidInCapital`	$45.44B	USD	Point-in-time
Treasury stock, at cost: 424 shares at March 31, 2019 and 425 shares at December 31, 2018	`TreasuryStockValue`	$28.23B	USD	Point-in-time
Treasury stock, at cost: 424 shares at March 31, 2019 and 425 shares at December 31, 2018	`TreasuryStockValue`	$28.22B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$40.91B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$41.86B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$433.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$102.00M	USD	Point-in-time
Total CVS health shareholders' equity	`StockholdersEquity`	$58.23B	USD	Point-in-time
Total CVS health shareholders' equity	`StockholdersEquity`	$59.69B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$318.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$320.00M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-38.68B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-37.70B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$219.77B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$196.46B	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$61.40B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$45.69B	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$249.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$50.00M	USD	1 Quarter
Total revenues	`Revenues`	$61.65B	USD	1 Quarter
Total revenues	`Revenues`	$45.74B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$37.25B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$37.51B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$13.46B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$1.33B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$8.25B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$4.91B	USD	1 Quarter
Total operating cost	`CostsAndExpenses`	$43.75B	USD	1 Quarter
Total operating cost	`CostsAndExpenses`	$58.96B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$2.00B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$2.69B	USD	1 Quarter
Interest expense	`InterestExpense`	$782.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$523.00M	USD	1 Quarter
Other expense (income)	`OtherNonoperatingIncomeExpense`	$-31.00M	USD	1 Quarter
Other expense (income)	`OtherNonoperatingIncomeExpense`	$3.00M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.47B	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.94B	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$472.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$512.00M	USD	1 Quarter
Net income	`ProfitLoss`	$1.43B	USD	1 Quarter
Net income	`ProfitLoss`	$998.00M	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-6.00M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.09	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.98	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.98	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.09	USD	1 Quarter
Weighted Average Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.30B	shares	1 Quarter
Weighted Average Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.02B	shares	1 Quarter
Weighted Average Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.02B	shares	1 Quarter
Weighted Average Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.30B	shares	1 Quarter
Dividends declared per share	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$58.87B	USD	1 Quarter
Cash receipts from customers	`ProceedsFromCustomers`	$43.37B	USD	1 Quarter
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$-35.10B	USD	1 Quarter
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$-35.65B	USD	1 Quarter
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$-1.09B	USD	1 Quarter
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$-12.95B	USD	1 Quarter
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$7.40B	USD	1 Quarter
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$4.27B	USD	1 Quarter
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$50.00M	USD	1 Quarter
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$250.00M	USD	1 Quarter
Interest Paid	`InterestPaidNet`	$545.00M	USD	1 Quarter
Interest Paid	`InterestPaidNet`	$1.12B	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$-53.00M	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$-53.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.35B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.95B	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$10.00M	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.99B	USD	1 Quarter
Purchase of investments	`PaymentsToAcquireInvestments`	$33.00M	USD	1 Quarter
Purchase of investments	`PaymentsToAcquireInvestments`	$2.05B	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$482.00M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$716.00M	USD	1 Quarter
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$353.00M	USD	1 Quarter
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$124.00M	USD	1 Quarter
Proceeds from sale of subsidiary	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	-	USD	1 Quarter
Proceeds from sale of subsidiary	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$725.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$2.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$10.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-131.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-891.00M	USD	1 Quarter
Net borrowings (repayments) of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$2.29B	USD	1 Quarter
Net borrowings (repayments) of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-1.28B	USD	1 Quarter
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$39.38B	USD	1 Quarter
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$882.00M	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.00M	USD	1 Quarter
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	-	USD	1 Quarter
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$446.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$649.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$508.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$107.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$101.00M	USD	1 Quarter
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$4.00M	USD	1 Quarter
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$44.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$5.00M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$816.00M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$38.14B	USD	1 Quarter
Cash and cash equivalents at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.17B	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.90B	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.26B	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.17B	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.90B	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.26B	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Net income	`ProfitLoss`	$1.43B	USD	1 Quarter
Net income	`ProfitLoss`	$998.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.11B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$644.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$114.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$55.00M	USD	1 Quarter
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$62.00M	USD	1 Quarter
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$153.00M	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-1.99B	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-857.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$1.00B	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$464.00M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-389.00M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-57.00M	USD	1 Quarter
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$-178.00M	USD	1 Quarter
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$-22.00M	USD	1 Quarter
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$236.00M	USD	1 Quarter
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$553.00M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$988.00M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-11.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.35B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.95B	USD	1 Quarter
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$40.36B	USD	1 Quarter
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.87B	USD	1 Quarter

Stockholders Equity 49 line items

Line Item	Tag	Value	Unit	Period
Treasury Stock, Shares, Held in Trust	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury Stock, Shares, Held in Trust	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury Stock, Shares, Held in Trust	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury Stock, Shares, Held in Trust	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury Stock, Value, Shares Held In Trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury Stock, Value, Shares Held In Trust	`TreasuryStockValueSharesHeldInTrust`	$31.00M	USD	Point-in-time
Treasury Stock, Value, Shares Held In Trust	`TreasuryStockValueSharesHeldInTrust`	$31.00M	USD	Point-in-time
Treasury Stock, Value, Shares Held In Trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common Stock, Value, Issued	`CommonStockValue`	$17.00M	USD	Point-in-time
Common Stock, Value, Issued	`CommonStockValue`	$17.00M	USD	Point-in-time
Common Stock, Value, Issued	`CommonStockValue`	$17.00M	USD	Point-in-time
Common Stock, Value, Issued	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock, balance at beginning of period (in shares)	`CommonStockSharesOutstanding`	1.30B	shares	Point-in-time
Common stock, balance at beginning of period (in shares)	`CommonStockSharesOutstanding`	1.29B	shares	Point-in-time
Adoption of new accounting standard	`CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption`	$178.00M	USD	Point-in-time
Adoption of new accounting standard	`CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption`	$-13.00M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$58.23B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$59.69B	USD	Point-in-time
Total equity at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-38.68B	USD	Point-in-time
Total equity at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Total equity at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Total equity at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-37.70B	USD	Point-in-time
Adoption of new accounting standard	`CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption`	$178.00M	USD	Point-in-time
Adoption of new accounting standard	`CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption`	$-13.00M	USD	Point-in-time
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-6.00M	USD	1 Quarter
Net income	`ProfitLoss`	$1.43B	USD	1 Quarter
Net income	`ProfitLoss`	$998.00M	USD	1 Quarter
Other Comprehensive Income	`OtherComprehensiveIncomeLossNetOfTax`	$344.00M	USD	1 Quarter
Other Comprehensive Income	`OtherComprehensiveIncomeLossNetOfTax`	$331.00M	USD	1 Quarter
Stockholders' Equity Attributable to Noncontrolling Interest at beginning of period	`MinorityInterest`	$318.00M	USD	Point-in-time
Stockholders' Equity Attributable to Noncontrolling Interest at beginning of period	`MinorityInterest`	$320.00M	USD	Point-in-time
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$175.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$112.00M	USD	1 Quarter
Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$-7.00M	USD	1 Quarter
Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$-49.00M	USD	1 Quarter
Dividends declared	`DividendsCommonStock`	$651.00M	USD	1 Quarter
Dividends declared	`DividendsCommonStock`	$508.00M	USD	1 Quarter
Other decreases in noncontrolling interest	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$-4.00M	USD	1 Quarter
Common stock, balance at end of period (in shares)	`CommonStockSharesOutstanding`	1.30B	shares	Point-in-time
Common stock, balance at end of period (in shares)	`CommonStockSharesOutstanding`	1.29B	shares	Point-in-time
Balance at end of period	`StockholdersEquity`	$58.23B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$59.69B	USD	Point-in-time
Stockholders' Equity Attributable to Noncontrolling Interest at end of period	`MinorityInterest`	$318.00M	USD	Point-in-time
Stockholders' Equity Attributable to Noncontrolling Interest at end of period	`MinorityInterest`	$320.00M	USD	Point-in-time
Total equity at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-38.68B	USD	Point-in-time
Total equity at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Total equity at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Total equity at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-37.70B	USD	Point-in-time

Comprehensive Income 16 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$1.43B	USD	1 Quarter
Net income	`ProfitLoss`	$998.00M	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$334.00M	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$343.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-4.00M	USD	1 Quarter
Other Comprehensive Income	`OtherComprehensiveIncomeLossNetOfTax`	$344.00M	USD	1 Quarter
Other Comprehensive Income	`OtherComprehensiveIncomeLossNetOfTax`	$331.00M	USD	1 Quarter
Comprehensive Income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.76B	USD	1 Quarter
Comprehensive Income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.34B	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-6.00M	USD	1 Quarter
Comprehensive Income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.75B	USD	1 Quarter
Comprehensive Income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.34B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.